Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. - Physician's Weekly

About The Expert

David A Braun

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Kelly Street

Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.

Kelly P Burke

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.

David L Cookmeyer

Harvard Medical School, Boston, MA 02215, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.

Thomas Denize

Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA.

Christina B Pedersen

Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark; Center for Genomic Medicine, Rigshospitalet – Copenhagen University Hospital, Copenhagen, Denmark.

Satyen H Gohil

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Academic Hematology, University College London, London, UK.

Nicholas Schindler

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Lucas Pomerance

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.

Laure Hirsch

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.

Ziad Bakouny

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Yue Hou

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Juliet Forman

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Teddy Huang

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Shuqiang Li

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Ang Cui

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge, MA 02139, USA.

Derin B Keskin

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

John Steinharter

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Gabrielle Bouchard

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Maxine Sun

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Erica M Pimenta

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.

Wenxin Xu

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.

Kathleen M Mahoney

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

Bradley A McGregor

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.

Michelle S Hirsch

Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA.

Steven L Chang

Harvard Medical School, Boston, MA 02215, USA; Division of Urologic Surgery, Brigham and Women’s Hospital, Boston, MA 02115, USA.

Kenneth J Livak

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

David F McDermott

Harvard Medical School, Boston, MA 02215, USA; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

Sachet A Shukla

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Lars R Olsen

Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark; Center for Genomic Medicine, Rigshospitalet – Copenhagen University Hospital, Copenhagen, Denmark.

Sabina Signoretti

Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Arlene H Sharpe

Harvard Medical School, Boston, MA 02215, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA; Evergrande Center for Immunologic Diseases, Harvard Medical School & Brigham and Women’s Hospital, Boston, MA 02115, USA.

Rafael A Irizarry

Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.

Toni K Choueiri

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.

Catherine J Wu

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: cwu@partners.org.

References

PubMed